Soligenix Novice Eulerpool

Soligenix Novice o delnici

Soligenix spremljajo številni novinarji in vlagatelji po vsem svetu. Najnovejše Soligenix novice zbiramo in objavljamo tukaj.

• 6. junij ·

  Yahoo
  Soligenix Highlights Dr. Ellen Kim’s Recent Q&A and the Promise of HyBryte™ in Ongoing Clinical Trials
• 13. maj ·

  Yahoo
  SNGX: Enrollment Continues in Confirmatory Phase 3 Trial of HyBryte™ in CTCL…
• 14. april ·

  Yahoo
  Positive Outcome in 75% of CTCL Patients Treated with HyBryte™ for 18 Weeks
• 21. marec ·

  Yahoo
  Soligenix Announces Recent Accomplishments and Year End 2024 Financial Results
• 6. marec ·

  Yahoo
  HyBryte™ Treatment Studies Presented at Two Medical Conferences in March
• 24. februar ·

  Yahoo
  SNGX: Presentation Highlights HyBryte Potential in CTCL…
• 4. februar ·

  Yahoo
  Soligenix to Present at BIO CEO & Investor Conference
• 17. december ·

  Yahoo
  Soligenix begins enrolling subjects in cutaneous T-cell lymphoma treatment trial
• 17. december ·

  Yahoo
  Soligenix initiates confirmatory Phase 3 trial of HyBryte
• 16. december ·

  Yahoo
  SNGX: Phase 3 FLASH2 Trial of HyBryte in CTCL Underway…